|
Onchocerciasis
Websites:
Carter Center - River Blindness
WHO - O. volvulus life-cycle
Mectizan
CDC Fact Sheet - Onchocerciasis
WHO - Onchocerciasis
Dr. Sampurna Roy - River Blindness
Histopathology
eMedicine - River Blindness
Encyclopædia
Britannica Online 2006 - Onchocerciasis
Articles:
Apple, David J.. Bulletin of the World
Health Organization, 2003, Vol. 81 Issue
10, p756-757
Boatin BA, Hougard JM, Alley ES, Akpoboua LK,
Yameogo L, Dembele N, Seketeli A, Dadzie KY.
1998. The impact of Mectizan on the
transmission of onchocerciasis. Ann Trop Med
Parasitol 92: S46-60.
Carabin, Heélène; Escalona, Marisela;
Marshall, Clare; Vivas-Martínez, Sarai;
Botto, Carlos; Joseph, Lawrence; Basáñez,
Mariía-Gloria.
Bulletin of the World Health Organization,
2003, Vol. 81 Issue 7, p482
Cheke, Robert A.; Tratalos, Jamie A..
Bioscience, Feb2007, Vol. 57 Issue 2,
p145-154
Dull HB, Meredith SE. "The Mectizan
Donation Programme--a 10-year report."
Annals of Tropical Medicine &
Parasitology 92 Suppl 1 (1998), S69-71.
Dracunculiasis
Websites:
Encyclopædia
Britannica Online 2006 - Dracunculiasis
WHO - Dracunculiasis
CDC Fact Sheet - Dracunculiasis
CDC - Morbidity and Mortality Weekly Report
Carter Center - Guinea Worm Eradication
Program
Carter Center - Donation Programs
Smithsonian NMNH - Copepod World
Filarial Genome Network - Dracunculus
medinensis
New York Times - Guinea worm: A rare and
stubborn pestilence
Articles:
Bimi L, Freeman AR, Eberhard ML, Ruiz-Tiben
E, Pieniazek NJ. 2005. Differentiating
Dracunculus medinensis from D.
insignis, by the sequence analysis of
the 18s rRNA gene. Annals of Tropical
Medicine and Parasitol 99: 511-517.
Hopkins DR, Ruiz-Tiben E, Downs P, Withers
PC, Jr., Maguire JH. 2005. Dracunculiasis
Eradication: The Final Inch. Am. J. Trop.
Med. Hyg. 73: 669-675.
Malaria
Websites:
Encyclopædia
Britannica
Online 2006 - Malaria
WHO - Malaria
CDC - Malaria
CDC -
Anopheles mosquito
McGraw Hill - Malaria animation
LiveScience - P. falciparum video
Articles:
Pouniotis DS,
Proudfoot O, Minigo G, Hanley JL, Plebanski
M. Malaria parasite interactions with the
human host. J Postgrad Med 2004; 50:30-34
Campbell, Neil A. et al. "Biology" Seventh
edition. Menlo Park, CA: Addison Wesley
Longman, Inc. 2005
Greenwood
BM, Bojang K, Whitty CJ, Targett GA (2005).
Greenwood B, Mutabingwa T (2002). "Malaria
in 2002".
Nature
415: 670–2.
Sachs J, Malaney P (2002). "The economic and
social burden of malaria".
Nature
415: 680-5.
Carter JA, Ross AJ, Neville BG, Obiero E,
Katana K, Mung'ala-Odera V, Lees JA, Newton
CR (2005).
"Developmental impairments following severe
falciparum malaria in children".
Trop Med Int Health
10: 3-10.
Warhurst DC, Williams JE (1996). "Laboratory
diagnosis of malaria".
J
Clin Pathol
49: 533–38.
Pattanasin S, Proux S, Chompasuk D,
Luwiradaj K, Jacquier P, Looareesuwan S,
Nosten F (2003). "Evaluation of a new
Plasmodium lactate dehydrogenase assay (OptiMAL-IT®)
for the detection of malaria".
Transact Royal Soc Trop Med
97: 672–4.
Mens PF, Schoone GJ, Kager PA, Schallig HDFH.
(2006). "Detection and identification of
human Plasmodium species with real-time
quantitative nucleic acid sequence-based
amplification".
Malaria Journal
5 (80).
Trager W, Jensen JB. (1976). "Human malaria
parasites in continuous culture".
Science
193(4254): 673-75.
Salom-Roig, X. et al. (2005)
Dual
molecules as new antimalarials.
Combinatorial Chemistry & High Throughput
Screening 8:49-62.
Lon CT, Tsuyuoka R, Phanouvong S,
et
al.
(2006). "Counterfeit and substandard
antimalarial drugs in Cambodia".
Trans R Soc Trop Med Hyg
100 (11): 1019–24.
.
Newton PN, Green MD, Fernández FM, Day NPJ,
White NJ. (2006). "Counterfeit
anti-infective drugs".
Lancet Infect Dis
6 (9): 602–13.
Ito J, Ghosh A, Moreira LA, Wimmer EA,
Jacobs-Lorena M (2002). "Transgenic
anopheline mosquitoes impaired in
transmission of a malaria parasite".
Nature
417: 387-8.
Imperial College, London, "Scientists create first transgenic malaria mosquito",
2000-06-22.
Jacobs-Lorena et al, "Researchers
genetically alter mosquitoes to impair
malaria transmission", Case
Western, 2002.
Killeen G, Fillinger U, Kiche I, Gouagna L,
Knols B (2002). "Eradication of Anopheles
gambiae from Brazil: lessons for malaria
control in Africa?".
Lancet Infect Dis
2 (10): 618-27.
Kwiatkowski, DP (2005). "How Malaria Has
Affected the Human Genome and What Human
Genetics Can Teach Us about Malaria".
Am
J Hum Genet
77: 171-92.
Malaria
drug resistance warning.
BBC News,
2005-06-06
Malaria drug
offers new hope. BBC News
2002-02-15.
Fungus
'may help malaria fight'. BBC
News,
2005-06-09
Gladwell,
Malcolm.. "The
Mosquito Killer", The New
Yorker,
2001-07-02.
MacGregor,
Fiona. "Scots
scientists boost malaria vaccine quest",
The Scotsman,
2005-01-16.
Tuberculosis
Websites:
Encyclopædia Britannica Online 2006 - Tuberculosis
WHO - Tuberculosis
CDC - Tuberculosis
University of Pittsburgh - Epidemiology of
Tuberculosis
CD Resource:
Topics in International Health. Tuberculosis,
revised edition. The Wellcome Trust, 2003.
Articles:
Davies PDO, Yew WW, Ganguly D,
et
al.
(2006). "Smoking and tuberculosis: the
epidemiological association and
pathogenesis".
Trans R Soc Trop Med Hyg
100: 291–8.
National Institute of Allergy and Infectious
Diseases. "First
U.S. Tuberculosis Vaccine Trial in 60 Years
Begins", National Institutes
of Health News, January 26, 2004.
Ha SJ, Jeon BY, Youn JI, Kim SC, Cho SN,
Sung YC (2005). "Protective effect of DNA
vaccine during chemotherapy on reactivation
and reinfection of Mycobacterium
Tuberculosis".
Gene Ther
12 (7): 634-8.
Ibanga HB, Brookes RH, Hill PC,
et
al.
(2006). "Early clinical trials witha new
tuberculosis vaccine, MVA85A, in
tuberculosis-endemic countries: issues in
study design".
Lancet Infect Dis
6 (8): 522–28.
R R Trail (April 1970). "Richard
Morton (1637-1698)".
Med Hist
14 (2): 166–174.
Stop TB Partnership. "London
tuberculosis rates now at Third World
proportions", PR Newswire
Europe Ltd., 2002-12-04.
Clark Lawlor. Consumption and Literature:
The Making of the Romantic Disease.
(Basingstoke, UK: Palgrave, 2006)
Joint Tuberculosis Committee of the British
Thoracic Society. Control and prevention
of tuberculosis in the United Kingdom: Code
of Practice 2000. Thorax 2000;55:887-901
Thomas Dormandy (1999). The White Death:
A History of Tuberculosis.
ISBN
0-8147-1927-9
Mountains Beyond Mountains: The Quest of Dr.
Paul Farmer, a Man Who Would Cure the World.
Tracy Kidder, Random House 2000.
ISBN
0-8129-7301-1. A nonfiction
account of treating TB in Haiti, Peru, and
elsewhere.
Ha
SJ, Jeon BY, Youn JI, Kim SC, Cho SN, Sung
YC. Protective effect of DNA vaccine during
chemotherapy on reactivation and reinfection
of Mycobacterium tuberculosis. Gene Ther.
2005 Feb 03;
Blumberg HM, Leonard MK Jr, Jasmer RM.
Update on the treatment of tuberculosis and
latent tuberculosis infection.
JAMA
2005 Jun 8;293(22):2776-84.
Nemery B, Yew WW, Albert R, Brun-Buisson C,
Macnee W, Martinez FJ, Angus DC, Abraham E.
Tuberculosis, nontuberculous lung infection,
pleural disorders, pulmonary function,
respiratory muscles, occupational lung
disease, pulmonary infections, and social
issues in AJRCCM in 2004. Am J Respir Crit
Care Med. 2005 Mar 15;171(6):554-62.
Ferrara G
et
al..
"Use
in routine clinical practice of two
commercial blood tests for diagnosis of
infection with Mycobacterium tuberculosis: a
prospective study".
Lancet
367 (9519): 1328–1334.
Steingart K, Henry M, Ng V,
et
al.
(2006). "Fluorescence versus conventional
sputum smear microscopy for tuberculosis: a
systematic review".
Lancet Infect Dis
6 (9): 570–81.
Lalvani A. ELISPOT Spotting latent
infection: the path to better tuberculosis
control. Thorax. 2003 Nov;58(11):916-8.
Editorial.
David
H. L. (1970). "Probability
Distribution of Drug-Resistant Mutants in
Unselected Populations of
Mycobacterium
tuberculosis". Appl
Microbiol 20
(5): 810-4.
British
Thoracic Society (1984). "A controlled trial
of six months' chemotherapy in pulmonary
tuberculosis. Final report: results during
the 36 months after the end of chemotherapy
and beyond.". Brit J Diseases Chest
78 (4): 330–36.
Ormerod LP, Horsfield N (1987).
"Short-course antituberculous chemotherapy
for pulmonary and pleural disease: five
years' experience in clinical practice".
Brit J Diseases Chest
81 (3): 268–71.
Kent
SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. "Tuberculous
Meningitis: A 30-Year Review". Clin
Infect Dis:
987–94.
Teoh
R, O'Mahony G, Yeung VTF (1986). "Polymorphonuclear
pleocytosis in the cerebrospinal fluid
during chemotherapy for tuberculous
meningitis". J Neurol
233 (4): 237-41.
Chang
AB et al
(1998). "Central nervous system tuberculosis
after resolution of miliary tuberculosis".
Pediatr Infect Dis J
17 (6): 519-523.
Thwaites
GE et al.
(2004). "Dexamethasone for the treatment of
tuberculous meningitis in adolescents and
adults". N Engl J Med
351 (17): 1741–51.
Roberts MT, Mendelson M, Meyer P, Carmichael
A, Lever AM (2003). "The use of thalidomide
in the treatment of intracranial
tuberculomas in adults: two case reports".
J
Infect
47 (3): 251–5.
Yee
D et al.
(2003). "Incidence of serious side effects
from first-line antituberculosis drugs among
patients treated for active tuberculosis".
Am J Resp Crit Care Med
167 (11): 1472–7.
Ormerod
L. P., Horsfield N. (1996). "Frequency and
type of reactions to antituberculosis drugs:
observations in routine treatment" 77 (1):
37–42.
Steel
M. A., Burk R. F., DesPrez R. M. (1991).
"Toxic hepatitis with isoniazid and rifampin:
a meta-analysis". Chest
99 (2): 465-471.
Drobac PC
et
al..
"Treatment
of Multidrug-Resistant Tuberculosis during
Pregnancy: Long-Term Follow-Up of 6 Children
with Intrauterine Exposure to Second-Line
Agents".
Clin Infect Dis
40 (11): 1689–92.
Breen
RAM, Miller RF, Gorsuch T, et al. (2006). "Virological response to highly active antiretroviral therapy
is unaffected by antituberculosis therapy".
J Infect Dis
193 (10): 1437–40.
.
Mitnick C
et
al.
(2003). "Community-based therapy for
multidrug-resistant tuberculosis in Lima,
Peru".
N
Eng J Med
348 (2): 119-128.
Leimane V.,
et
al.
(2005). "Clinical outcome of individualised
treatment of multidrug-resistant
tuberculosis in Latvia: a retrospective
cohort study".
Lancet
365 (9456): 318-26.
Schön
T, Elias D, Moges F, et al.
(2003). "Arginine
as an adjuvant to chemotherapy improves
clinical outcome in active tuberculosis".
Eur Respir J
21: 483–88.
Rockett
KA, Brookes R, Udalova I, et al. (1998). "1,25-Dihydroxyvitamin
D3 induces nitric oxide synthase and
suppresses growth of
Mycobacterium
tuberculosis
in a human macrophage-like cell line".
Infect Immunity
66 (11): 5314–21.
Shubin
H, Sherson J, Pennes E, Glaskin A,
Sokmensuer A. (1958). "Prochlorperazine (compazine)
as an aid in the treatment of pulmonary
tuberculosis". Antibiotic Med Clin
Ther. 5 (5):
305–9.
Wayne LG, Sramek HA (1994). "Metronidazole
is bactericidal to dormant cells of
Mycobacterium tuberculosis".
Antimicrob Agents Chemother
38 (9): 2054–58.
Stover CK, Warrener P, VanDevanter DR,
et
al.
(2000). "A small-molecule nitroimidazopyran
drug candidate for the treatment of
tuberculosis".
Nature
405 (6789): 962–6.
Andries K, Verhasselt P, Guillemont J,
et
al.
(2005). "A diarylquinoline drug active on
the ATP-synthase of
Mycobacterium tuberculosis".
Science
307 (5707): 223–27.
Schechter
M, Zajdenverg R, Falco G, Barnes G,
Faulhaber J, Coberly J, Moore R, Chaisson R
(2006). "Weekly rifapentine/isoniazid or
daily rifampin/pyrazinamide for latent
tuberculosis in household contacts".
Am J Respir Crit Care Med
173 (8): 922–6.
Martin Cassidy. "Badgers
targeted over bovine TB,"
BBC
News, 2 December, 2004.
"'Virtually
untreatable' TB found,"
BBC News,
2006-09-06.
HIV/AIDS
Websites:
Encyclopædia
Britannica Online 2006 - AIDS
HowStuffWorks - How AIDS Works
Avert - International AIDS Charity
UNAIDS
CDC - HIV/AIDS
WHO - HIV Infections
CNN - AIDS: Africa in Peril
TIME Magazine - Death Stalks a Continent
CD Resource:
Topics in International Health. HIV/AIDS,
revised edition. The Wellcome Trust, 2003.
Articles: (links
to some of the articles are included)
Marx, J. L. (1982). "New disease baffles
medical community".
Science
217
(4560): 618-621.
Palella, F. J. Jr, Delaney, K. M., Moorman,
A. C., Loveless, M. O., Fuhrer, J., Satten,
G. A., Aschman and D. J., Holmberg, S. D.
(1998). "Declining morbidity and mortality
among patients with advanced human
immunodeficiency virus infection. HIV
Outpatient Study Investigators".
N.
Engl. J. Med
338 (13): 853-860.
Morgan, D., Mahe, C., Mayanja, B., Okongo,
J. M., Lubega, R. and Whitworth, J. A.
(2002). "HIV-1 infection in rural Africa: is
there a difference in median time to AIDS
and survival compared with that in
industrialized countries?".
AIDS
16 (4): 597-632.
Morgan, D., Mahe, C., Mayanja, B. and
Whitworth, J. A. (2002). "Progression to
symptomatic disease in people infected with
HIV-1 in rural Uganda: prospective cohort
study".
BMJ
324 (7331): 193-196.
Tang, J. and Kaslow, R. A. (2003). "The
impact of host genetics on HIV infection and
disease progression in the era of highly
active antiretroviral therapy".
AIDS
17 (Suppl 4): S51-S60.
Campbell, G. R., Pasquier, E., Watkins, J.,
Bourgarel-Rey, V., Peyrot, V., Esquieu, D.,
Barbier, P., de Mareuil, J., Braguer, D.,
Kaleebu, P., Yirrell, D. L. and Loret E. P.
(2004). "The glutamine-rich region of the
HIV-1 Tat protein is involved in T-cell
apoptosis".
J.
Biol. Chem.
279 (46): 48197-48204.
.
Kumaranayake, L. and Watts, C. (2001).
"Resource allocation and priority setting of
HIV/AIDS interventions: addressing the
generalized epidemic in sub-Saharan Africa".
J.
Int. Dev.
13 (4): 451-466.
Holmes, C. B., Losina, E., Walensky, R. P.,
Yazdanpanah, Y., Freedberg, K. A. (2003).
"Review of human immunodeficiency virus type
1-related opportunistic infections in
sub-Saharan Africa".
Clin. Infect. Dis.
36 (5): 656-662.
Guss, D. A. (1994). "The acquired immune
deficiency syndrome: an overview for the
emergency physician, Part 1".
J.
Emerg. Med.
12 (3): 375-497.
Lawn, S. D. (2004). "AIDS in Africa: the
impact of coinfections on the pathogenesis
of HIV-1 infection".
J.
Infect. Dis.
48 (1): 1-12.
.
Senkaali, D., Muwonge, R., Morgan, D.,
Yirrell, D., Whitworth, J. and Kaleebu, P.
(2005). "The relationship between HIV type 1
disease progression and V3 serotype in a
rural Ugandan cohort".
AIDS Res. Hum. Retroviruses.
20 (9): 932-937.
.
Feldman, C. (2005). "Pneumonia associated
with HIV infection".
Curr. Opin. Infect. Dis.
18 (2): 165-170.
.
Decker, C. F. and Lazarus, A. (2000).
"Tuberculosis and HIV infection. How to
safely treat both disorders concurrently".
Postgrad Med.
108 (2): 57-60, 65-68.
.
Zaidi, S. A. and Cervia, J. S. (2002).
"Diagnosis and management of infectious
esophagitis associated with human
immunodeficiency virus infection".
J.
Int. Assoc. Physicians AIDS Care (Chic Ill)
1 (2): 53-62.
.
Guerrant, R. L., Hughes, J. M., Lima, N. L.,
Crane, J. (1990). "Diarrhea in developed and
developing countries: magnitude, special
settings, and etiologies".
Rev. Infect. Dis.
12 (Suppl 1): S41-S50. .
Luft,
B. J. and Chua, A. (2000). "Central Nervous
System Toxoplasmosis in HIV Pathogenesis,
Diagnosis, and Therapy". Curr.
Infect. Dis. Rep.
2 (4): 358-362.
.
Sadler,
M. and Nelson, M. R. (1997). "Progressive
multifocal leukoencephalopathy in HIV".
Int. J. STD AIDS
8 (6): 351-357.
.
Gray,
F., Adle-Biassette, H., Chrétien, F., Lorin
de la Grandmaison, G., Force, G., Keohane,
C. (2001). "Neuropathology and
neurodegeneration in human immunodeficiency
virus infection. Pathogenesis of HIV-induced
lesions of the brain, correlations with
HIV-associated disorders and modifications
according to treatments". Clin.
Neuropathol.
20 (4): 146-155.
.
Grant, I., Sacktor, H., and McArthur, J.
(2005). “HIV
neurocognitive disorders”, H. E.
Gendelman, I. Grant, I. Everall, S. A.
Lipton, and S. Swindells. (ed.)
The Neurology of AIDS,
2nd, London, U.K.: Oxford University Press,
357-373.
Satishchandra, P., Nalini, A., Gourie-Devi,
M., Khanna, N., Santosh, V., Ravi, V.,
Desai, A., Chandramuki, A., Jayakumar, P.
N., and Shankar, S. K. (2000). "Profile of
neurologic disorders associated with
HIV/AIDS from Bangalore, south India
(1989-96)".
Indian J. Med. Res.
11: 14-23.
.
Wadia,
R. S., Pujari, S. N., Kothari, S., Udhar,
M., Kulkarni, S., Bhagat, S., and
Nanivadekar, A. (2001). "Neurological
manifestations of HIV disease". J.
Assoc. Physicians India
49: 343-348.
.
Boshoff, C. and Weiss, R. (2002).
"AIDS-related malignancies".
Nat. Rev. Cancer
2 (5): 373-382.
.
Yarchoan, R., Tosatom G. and Littlem R. F.
(2005). "Therapy insight: AIDS-related
malignancies - the influence of antiviral
therapy on pathogenesis and management".
Nat. Clin. Pract. Oncol.
2 (8): 406-415.
.
Bonnet,
F., Lewden, C., May, T., Heripret, L.,
Jougla, E., Bevilacqua, S., Costagliola, D.,
Salmon, D., Chene, G. and Morlat, P. (2004).
"Malignancy-related causes of death in human
immunodeficiency virus-infected patients in
the era of highly active antiretroviral
therapy". Cancer
101 (2): 317-324.
.
Skoulidis, F., Morgan, M. S., and MacLeod,
K. M. (2004). "Penicillium marneffei: a
pathogen on our doorstep?".
J.
R. Soc. Med.
97 (2): 394-396.
.
Smith, D. K., Grohskopf, L. A., Black, R.
J., Auerbach, J. D., Veronese, F., Struble,
K. A., Cheever, L., Johnson, M., Paxton, L.
A., Onorato, I. A. and Greenberg, A. E.
(2005). "Antiretroviral
Postexposure Prophylaxis After Sexual,
Injection-Drug Use, or Other Nonoccupational
Exposure to HIV in the United States".
MMWR
54 (RR02): 1-20.
Donegan, E., Stuart, M., Niland, J. C.,
Sacks, H. S., Azen, S. P., Dietrich, S. L.,
Faucett, C., Fletcher, M. A., Kleinman, S.
H., Operskalski, E. A., et al. (1990).
"Infection with human immunodeficiency virus
type 1 (HIV-1) among recipients of
antibody-positive blood donations".
Ann. Intern. Med.
113 (10): 733-739.
.
Coovadia, H. (2004). "Antiretroviral
agents—how best to protect infants from HIV
and save their mothers from AIDS".
N.
Engl. J. Med.
351 (3): 289-292.
.
Kaplan, E. H. and Heimer, R. (1995). "HIV
incidence among New Haven needle exchange
participants: updated estimates from syringe
tracking and testing data".
J.
Acquir. Immune Defic. Syndr. Hum. Retrovirol.
10 (2): 175-176.
.
European Study Group on Heterosexual
Transmission of HIV (1992). "Comparison of
female to male and male to female
transmission of HIV in 563 stable couples".
BMJ.
304 (6830): 809-813.
.
Varghese, B., Maher, J. E., Peterman, T. A.,
Branson, B. M. and Steketee, R. W. (2002).
"Reducing the risk of sexual HIV
transmission: quantifying the per-act risk
for HIV on the basis of choice of partner,
sex act, and condom use".
Sex. Transm. Dis.
29 (1): 38-43.
.
Bell, D. M. (1997). "Occupational risk of
human immunodeficiency virus infection in
healthcare workers: an overview.".
Am. J. Med.
102 (5B): 9-15.
.
Leynaert, B., Downs, A. M. and de Vincenzi,
I. (1998). "Heterosexual transmission of
human immunodeficiency virus: variability of
infectivity throughout the course of
infection. European Study Group on
Heterosexual Transmission of HIV".
Am. J. Epidemiol.
148 (1): 88-96.
.
Rothenberg, R. B., Scarlett, M., del Rio,
C., Reznik, D. and O'Daniels, C. (1998).
"Oral transmission of HIV".
AIDS
12 (16): 2095-2105.
.
Mastro TD, de Vincenzi I (1996).
"Probabilities of sexual HIV-1
transmission".
AIDS
10 (Suppl A): S75-S82. .
Laga, M., Nzila, N., Goeman, J. (1991). "The
interrelationship of sexually transmitted
diseases and HIV infection: implications for
the control of both epidemics in Africa".
AIDS
5 (Suppl 1): S55-S63. .
Tovanabutra, S., Robison, V., Wongtrakul,
J., Sennum, S., Suriyanon, V., Kingkeow, D.,
Kawichai, S., Tanan, P., Duerr, A. and
Nelson, K. E. (2002). "Male viral load and
heterosexual transmission of HIV-1 subtype E
in northern Thailand".
J.
Acquir. Immune. Defic. Syndr.
29 (3): 275-283.
.
Sagar, M., Lavreys, L., Baeten, J. M.,
Richardson, B. A., Mandaliya, K.,
Ndinya-Achola, J. O., Kreiss, J. K., and
Overbaugh, J. (2004). "Identification of
modifiable factors that affect the genetic
diversity of the transmitted HIV-1
population".
AIDS
18 (4): 615-619.
.
Lavreys, L., Baeten, J. M., Martin, H. L.
Jr., Overbaugh, J., Mandaliya, K.,
Ndinya-Achola, J., and Kreiss, J. K. (2004).
"Hormonal contraception and risk of HIV-1
acquisition: results of a 10-year
prospective study".
AIDS
18 (4): 695-697.
.
Cayley, W. E. Jr. (2004). "Effectiveness of
condoms in reducing heterosexual
transmission of HIV".
Am. Fam. Physician
70 (7): 1268-1269.
.
Fisher, I.. "Ideals
Collide as Vatican Rethinks Condom Ban",
The New York Times,
2006-05-02.
Catholic Church (1997). “Offenses
against chastity”,
Catechism of the Catholic Church : Second
Edition.
Vatican: Amministrazione Del Patrimonio
Della Sede Apostolica, 2353.
The Economist (2005).
Too much morality, too little sense.
Siegfried, N., Muller, M., Deeks, J.,
Volmink, J., Egger, M., Low, N., Walker, S.
and Williamson, P. (2005). "HIV and male
circumcision--a systematic review with
assessment of the quality of studies".
Lancet Infect. Dis.
5 (3): 165-173.
.
Williams BG, Lloyd-Smith JO, Gouws E,
Hankins C, Getz WM, Hargrove J, de Zoysa I,
Dye C, Auvert B. (2006). "The Potential
Impact of Male Circumcision on HIV in
Sub-Saharan Africa.".
PLoS Med
3 (7): e262.
.
Various (2005).
Repeated Use of Unsterilized Blades in
Ritual Circumcision Might Contribute to HIV
Spread in S. Africa, Doctors Say.
Kaisernetwork.org.
Fan, H. (2005). Fan, H., Conner, R. F. and
Villarreal, L. P. eds
AIDS: science and society,
4th, Boston, MA: Jones and Bartlett
Publishers.
ISBN 0-7637-0086-X.
United Nations General Assembly (2001).
Declaration of Commitment on HIV/AIDS
Global Crisis — Global Action.
Sperling, R. S., Shapirom D. E., Coombsm R.
W., Todd, J. A., Herman, S. A., McSherry, G.
D., O'Sullivan, M. J., Van Dyke, R. B.,
Jimenez, E., Rouzioux, C., Flynn, P. M. and
Sullivan, J. L. (1996). "Maternal viral
load, zidovudine treatment, and the risk of
transmission of human immunodeficiency virus
type 1 from mother to infant".
N.
Engl. J. Med.
335 (22): 1621-1629.
.
Dias, S. F., Matos, M. G. and Goncalves, A.
C. (2005). "Preventing HIV transmission in
adolescents: an analysis of the Portuguese
data from the Health Behaviour School-aged
Children study and focus groups".
Eur. J. Public Health
15 (3): 300-304.
.
Department of Health and Human Services
(February, 2006).
A Pocket Guide to Adult HIV/AIDS Treatment
February 2006 edition.
Palella, F. J., Delaney, K. M., Moorman, A.
C., Loveless, M. O., Fuhrer, J., Satten, G.
A., Aschman, D. J. and Holmberg, S. D.
(1998). "Declining morbidity and mortality
among patients with advanced human
immunodeficiency virus infection".
N.
Engl. J. Med.
338 (13): 853-860.
.
Martinez-Picado, J., DePasquale, M. P.,
Kartsonis, N., Hanna, G. J., Wong, J., Finzi,
D., Rosenberg, E., Gunthard, H. F., Sutton,
L., Savara, A., Petropoulos, C. J.,
Hellmann, N., Walker, B. D., Richman, D. D.,
Siliciano, R. and D'Aquila, R. T. (2000).
"Antiretroviral resistance during successful
therapy of human immunodeficiency virus type
1 infection".
Proc. Natl. Acad. Sci. U. S. A.
97 (20): 10948-10953.
.
Dybul, M., Fauci, A. S., Bartlett, J. G.,
Kaplan, J. E., Pau, A. K.; Panel on Clinical
Practices for Treatment of HIV. (2002).
"Guidelines for using antiretroviral agents
among HIV-infected adults and adolescents".
Ann. Intern. Med.
137 (5 Pt 2): 381-433.
.
Blankson, J. N., Persaud, D., Siliciano, R.
F. (2002). "The challenge of viral
reservoirs in HIV-1 infection".
Annu. Rev. Med.
53: 557-593.
.
Wood, E., Hogg, R. S., Yip, B., Harrigan, P.
R., O'Shaughnessy, M. V. and Montaner, J. S.
(2003). "Is there a baseline CD4 cell count
that precludes a survival response to modern
antiretroviral therapy?".
AIDS
17 (5): 711-720.
.
Chene, G., Sterne, J. A., May, M.,
Costagliola, D., Ledergerber, B., Phillips,
A. N., Dabis, F., Lundgren, J., D'Arminio
Monforte, A., de Wolf, F., Hogg, R., Reiss,
P., Justice, A., Leport, C., Staszewski, S.,
Gill, J., Fatkenheuer, G., Egger, M. E. and
the Antiretroviral Therapy Cohort
Collaboration. (2003). "Prognostic
importance of initial response in HIV-1
infected patients starting potent
antiretroviral therapy: analysis of
prospective studies".
Lancet
362 (9385): 679-686.
.
Becker SL, Dezii CM, Burtcel B, Kawabata H,
Hodder S. (2002). "Young HIV-infected adults
are at greater risk for medication
nonadherence".
MedGenMed.
4 (3): 21.
.
Nieuwkerk, P., Sprangers, M., Burger, D.,
Hoetelmans, R. M., Hugen, P. W., Danner, S.
A., van Der Ende, M. E., Schneider, M. M.,
Schrey, G., Meenhorst, P. L., Sprenger, H.
G., Kauffmann, R. H., Jambroes, M., Chesney,
M. A., de Wolf, F., Lange, J. M. and the
ATHENA Project. (2001). "Limited Patient
Adherence to Highly Active Antiretroviral
Therapy for HIV-1 Infection in an
Observational Cohort Study".
Arch. Intern. Med.
161 (16): 1962-1968.
.
Kleeberger, C., Phair, J., Strathdee, S.,
Detels, R., Kingsley, L. and Jacobson, L. P.
(2001). "Determinants of Heterogeneous
Adherence to HIV-Antiretroviral Therapies in
the Multicenter AIDS Cohort Study".
J.
Acquir. Immune Defic. Syndr.
26 (1): 82-92.
.
Heath,
K. V., Singer, J., O'Shaughnessy, M. V.,
Montaner, J. S. and Hogg, R. S. (2002).
"Intentional Nonadherence Due to Adverse
Symptoms Associated With Antiretroviral
Therapy". J. Acquir. Immune Defic.
Syndr. 31
(2): 211-217.
.
Montessori, V., Press, N., Harris, M., Akagi,
L., Montaner, J. S. (2004). "Adverse effects
of antiretroviral therapy for HIV
infection.".
CMAJ
170 (2): 229-238.
.
Saitoh, A., Hull, A. D., Franklin, P. and
Spector, S. A. (2005). "Myelomeningocele in
an infant with intrauterine exposure to
efavirenz".
J.
Perinatol.
25 (8): 555-556.
.
Ferrantelli F, Cafaro A, Ensoli B. (2004).
"Nonstructural HIV proteins as targets for
prophylactic or therapeutic vaccines".
Curr Opin Biotechnol.
15 (6): 543-556.
.
Laurence J. (2006). "Hepatitis A and B virus
immunization in HIV-infected persons".
AIDS Reader
16 (1): 15-17.
.
Mills, E., Wu, P. and Ernst, E. (2005).
"Complementary therapies for the treatment
of HIV: in search of the evidence.".
Int. J. STD AIDS.
16 (6): 395-403.
.
World Bank (2005).
Evaluating the World Bank's Assistance for
Fighting the HIV/AIDS Epidemic.
Greener, R. (2002). “AIDS
and macroeconomic impact”, S, Forsyth
(ed.)
State of The Art: AIDS and Economics
49-55
Bollinger, L. and Stover, J. (1999).
The Economic Impact of AIDS
Over, M. (1992). "The macroeconomic impact
of AIDS in Sub-Saharan Africa, Population
and Human Resources Department".
The World Bank.
Bonnel, R. (2000). "HIV/AIDS and Economic
Growth: A Global Perspective".
S.
A. J. Economics
68 (5): 820-855.
Bell, C., Gersbach, H. and Devarajan, S.
(2003).
The long-run economic costs of AIDS: theory
and an application to South Africa.
eldis.
Herek, G. M. and Capitanio, J. P. (1999).
AIDS Stigma and sexual prejudice (PDF).
Am. Behav, Scientist.
Snyder M, Omoto AM, Crain AL. (1999).
"Punished for their good deeds:
stigmatization for AIDS volunteers".
American Behavioral Scientist
42 (7): 1175-1192.
Herek GM, Capitanio JP, Widaman KF. (2002).
"HIV-related
stigma and knowledge in the United States:
prevalence and trends, 1991-1999.
Am. J. Public Health.
92 (3): 371-377.
Zhu, T., Korber, B. T., Nahmias, A. J.,
Hooper, E., Sharp, P. M. and Ho, D. D.
(1998). "An African HIV-1 Sequence from 1959
and Implications for the Origin of the
Epidemic".
Nature
391 (6667): 594-597.
Kolata, G.. "Boy's
1969 death suggests AIDS invaded U.S.
several times", The New York Times,
1987-10-28.
Hooper, E. (1997). "Sailors
and star-bursts, and the arrival of HIV".
BMJ
315 (7123): 1689-1691.
.
Reeves, J. D. and Doms, R. W (2002). "Human
Immunodeficiency Virus Type 2".
J.
Gen. Virol.
83 (Pt 6): 1253-1265.
.
Keele, B. F., van Heuverswyn, F., Li, Y. Y.,
Bailes, E., Takehisa, J., Santiago, M. L.,
Bibollet-Ruche, F., Chen, Y., Wain, L. V.,
Liegois, F., Loul, S., Mpoudi Ngole, E.,
Bienvenue, Y., Delaporte, E., Brookfield, J.
F. Y., Sharp, P. M., Shaw, G. M., Peeters,
M., Hahn, B. H. (2006). "Chimpanzee
Reservoirs of Pandemic and Nonpandemic HIV-1".
Science
Online
2006-05-25.
Curtis, T. (1992). "The
origin of AIDS".
Rolling Stone
(626): 54-59, 61, 106, 108.
Hooper, E. (1999).
The River : A Journey to the Source of HIV
and AIDS,
1st, Boston, MA: Little Brown & Co, 1-1070.
ISBN 0-316-37261-7.
Berry N, Jenkins A, Martin J, Davis C, Wood
D, Schild G, Bottiger M, Holmes H, Minor P,
Almond N (2005). "Mitochondrial DNA and
retroviral RNA analyses of archival oral
polio vaccine (OPV CHAT) materials: evidence
of macaque nuclear sequences confirms
substrate identity.".
Vaccine
23: 1639-1648.
.
Duesberg, P. H. (1988). "HIV is not the
cause of AIDS".
Science
241 (4865): 514, 517.
.
Papadopulos-Eleopulos, E., Turner, V. F.,
Papadimitriou, J., Page, B., Causer, D.,
Alfonso, H., Mhlongo, S., Miller, T.,
Maniotis, A. and Fiala, C. (2004). "A
critique of the Montagnier evidence for the
HIV/AIDS hypothesis".
Med Hypotheses
63 (4): 597-601.
.
Cohen, J. (1994). "The
Duesberg phenomenon".
Science
266 (5191): 1642-1644.
.
Various (2006-08-13).
HIV Science and Responsible Journalism.
Seminar at the XVI International AIDS
Conference.
Kaiser Family Foundation.
Cohen, J. (1994). "The
Controversy over HIV and AIDS".
Science
266 (5191): 1642-1649.
Glauser, M. P., Francioli, P. (1984).
"Clinical and epidemiological survey of
acquired immune deficiency syndrome in
Europe".
Eur. J. Clin. Microbiol.
3 (1): 55-58.
Professor
Alan Whiteside (2003),
'Painting the Picture - Impact of AIDS in
Development in Africa' , Science in
Africa Website, May
Pope H.
(1995),'AIDS set to engulf South Africa',
the Independent, March 8
Department of
Health (2000),'HIV/AIDS/STD
Strategic Plan for South Africa: 2000-2005'
Reuters News
Media (2001),'Glaxo
gives up rights to AIDS drugs in South
Africa', October 6th
South African
Government Information website (2005),'Implementation
of the Comprehensive Plan on Prevention
Treatment and Care of HIV and AIDS: Fact
sheet', 23rd November
NPR (2006),
'Q&A: Access to HIV/AIDS Care in South
Africa'
Bbc.co.uk
(22nd June 2006),
'SA prisoners win AIDS drug case'
Kaisernetwork.org (May 2003),
'About 41% of South Africa's Prison
Population is HIV-Positive, Study Says'
AIDS Journal
(2005), Volume 19(1),
'Impact of African Herbal Medicines on
Antiretroviral Metabolism', p 95-97, 3rd
January
Treatment
Action Campaign (2005),
'Equal Treatment' Newsletter, May
UNDP (2003),
'Human Development Reports: Adult Literacy
Rates'
IRIN Plus
News (2005),
'South Africa: men falling through the
cracks', 25th July
Department of
Health (2006),
'Republic of South Africa: Progress Report
on Declaration of Commitment on HIV and
AIDS'
UNAIDS,
2006 Report on the global AIDS epidemic,
Annex 1 [country profiles, South Africa]
The Guardian
[UK] (2003),
'South Africa pins hopes on hip safe sex
campaign', 22nd May
IRIN Plus
News (2005),
'Global Fund withdraws support for LoveLife',
19th December
IOL (2003),
'Gays ignored in AIDS awareness campaigns',
September
IOL (2006),
'HIV 'increasing in gay men and
prostitutes''
Iclinic
(2000),
'How Can a Virus Cause a Syndrome? Asks
Mbeki', September 21
Science
(2000),
'SOUTH AFRICA: AIDS Researchers Decry
Mbeki's Views on HIV', Vol.288. no.
5466, pp. 590 - 591, 28th April
BBC.co.uk
(2000),
'Controversy Dogs AIDS Forum', 10th July
ANC (2002),
Statement of cabinet on HIV/AIDS, 6th
May
Sunday Herald
(18th June 2006),
'Apartheid might be over, but the struggle
goes on'
Mail &
Guardian Online (2006),
'Rath Defies Order to Remover Web Slander',
10th March
Lawn SD, Myer
L, Orrell C, Bekker LG, Wood R. (2005),
'Early mortality among adults accessing a
community-based antiretroviral service in
South Africa: implications for programme
design', AIDS. 2005 Dec 2;19(18):2141-8.
IOL, (2006)
'Zuma Showered to Reduce HIV Risk', 5th
April
Mail and
Guardian Online (2006),
'ARV Programme Less than the Sum of its
(Monetary) Parts', 15th March
Inter Press
Service (2000),
'UN Highlights Link Between AIDS and
Poverty', October 23rd
'Address by Deputy President Thabo Mbeki:
Declaration of Partnership Against AIDS',
(1998) 9th October
Steinberg M.,
Johnson S. et al. (2002) 'Hitting home: how
households cope with the HIV/AIDS epidemic',
Henry J. Kaiser Foundation & Health Systems
Trust, October
BBC.co.uk
(2005),
'Mandela's eldest son dies of Aids', 6th
January
Crime
Information Analysis Centre,
'Rape in the RSA for the period April to
March 2001/2002 to 2004/2005'
UNICEF
(2006),
'Report on violence against women and HIV
and AIDS prevention'
Department of
Health (2006),
'Republic of South Africa: Progress Report
on Declaration of Commitment on HIV and
AIDS'
Mail and
Guardian Online (2006),
'ARV Programme Less than the Sum of its
(Monetary) Parts', 15th March
Agence
France-Presse (2004),
'South African health ministry sees AIDS
pandemic stabilising', 23rd September
San Francisco
Chronicle (2000),
'Mbeki's HIV Stand Angers Delegates,
Hundreds walk out on his speech' 10th
July
UNFPA
website,
Condom Programming
Shelton J.D.
and Johnston B. (2001),
'Condom gap in Africa: evidence from donor
agencies and key informants'
Kaisernetwork.org (September 2005),
'US has increased global condom distribution
in recent years, targeting mostly high-risk
groups'
The Global
Fund to fight AIDS, Tuberculosis and Malaria
(September 2005),
Grants to Countries in Africa, Rounds 1-5
Funding
The Global
Fund to fight AIDS, Tuberculosis and Malaria
website,
FAQ
PEPFAR
(February 2006),
'Action Today, A Foundation For Tomorrow:
Second Annual Report to Congress on the
President's Emergency Plan for AIDS Relief'
<<Previous Page Next Page>> |
